Newsletters

09.24.19

State Innovation in Integrated Care for Dual Eligibles

Editor’s Note: Dual eligibles—those eligible for both Medicare and Medicaid—are among the most costly and complex enrollees in both programs.


08.26.19

New Opportunities to Advance Integrated Care for Dual Eligibles

Dual eligibles are an exceedingly high-need, high-cost population.


07.22.19

New Webinar: New Opportunities to Advance Integrated Care for Dual Eligibles

Dual eligibles—those eligible for both Medicare and Medicaid—are among the most costly and complex enrollees in both programs.


12.18.17

Part 1: Megatrends Reinventing How Patients Think

In early 2017, California Assembly member Jim Wood introduced Bill AB-265, banning the use of copay coupons in California when a generic equivalent drug covered by an individual’s health plan exists.


11.21.17

Fraud and Abuse 2017: Understanding Trends and Avoiding Actions

Under the Trump administration, healthcare fraud will remain a key focus.


10.24.17

A New Look at Digital Health Business Models

Few observers doubt that machine learning, voice assistants and technologies we haven’t even heard of yet will supplant our traditional “brick-and-mortar” health system.


08.23.17

By Antitrust Standards, When Is a Firm Really Failing?

The “failing firm” defense as a justification for permitting a merger that may otherwise lessen competition gets considerable play in healthcare transactions.


06.22.17

HIPAA and Emerging Technologies

Cybersecurity is a high priority across the Trump administration. In April, the Department of Health and Human Services (HHS) announced that it will establish a cyberthreat nerve center, modeled after Homeland Security’s National Cybersecurity and Communications Integration Center, to assess ...


05.24.17

Mapping the Healthcare M&A Landscape Under the New Administration

Healthcare M&A deal volume has been robust over the past five years and shows few signs of slowing down. Activity peaked in 2015—the year of the megadeal, particularly in the managed care and pharmaceutical arenas—with almost 1,100 deals approaching $100 billion in aggregate value.


02.22.17

Securing the Safety Net for America's Vulnerable Populations

Many older Americans have insufficient income and assets to protect them through retirement.